Open Access
HOW I DO IT
Anatomic GreenLight laser vaporization-incision technique for benign prostatic hyperplasia using the XPS LBO-180W system: How I do it
Kyle W. Law1, Dean S. Elterman2, Hannes Cash3, Enrique Rijo4, Bilal Chughtai5, Vincent Misrai6, Kevin C. Zorn1
1
Department of Urology, University of Montreal Hospital Center CHUM, Montreal, Quebec, Canada
2
Division of Urology, University Health Network, University of Toronto, Toronto, Ontario, Canada
3
Department of Urology, Charité – Universitaetsmedizin Berlin, Berlin, Germany
4
Department of Urology, Hospital Quironsalud Barcelona, Barcelona, Spain
5
Department of Urology, Weill Cornell Medical College, New York, New York
6
Department of Urology, Clinique Pasteur, Toulouse, France
Address correspondence to Dr. Kevin C. Zorn, Department
of Urology, University of Montreal Hospital Center (CHUM),
235 Rene Levesque East, Suite 301, Montreal, QC H2X 1N8
Canada
Canadian Journal of Urology 2019, 26(5), 9963-9972.
Abstract
For men experiencing lower urinary tract symptoms
(LUTS) refractory to medical therapy, there have been
numerous developments in the treatment options offered
for benign prostatic hyperplasia (BPH) in the recent
years. Transurethral resection of the prostate (TURP) has
remained the reference standard for men with prostates
sized 30 cc-80 cc, while open prostatectomy is universally
guidelines-recommended in the absence of enucleation,
for men with prostates larger than 80 cc-100 cc. While
these techniques are effective, they have the potential for
bleeding complications requiring transfusions, electrolyte
abnormalities such as TURP syndrome, and often require
prolonged hospitalization. GreenLight photoselective
vaporization (GL-PVP) with the XPS LBO-180W
system offers a minimally invasive treatment that can
be carried out on essential any sized prostate gland. In
addition, the GL-PVP procedure can be done as a same
day discharge surgery requiring no overnight hospital
admission and allows patients to continue any necessary
anti-coagulants given the significantly reduced risks of bleeding complications or TURP syndrome. In 2005, the
anatomic vaporization-incision technique (VIT) using the
XPS LBO-180W system was described to address larger
prostate volumes. VIT combines principles of traditional
GL-PVP and enucleation techniques to identify the
reference surgical capsule early-on into the surgery and
resect portions of prostate adenoma without the need for
tissue morcellation. Early studies comparing anatomic
VIT to standard PVP outcomes demonstrated significant
improvements of IPSS and uroflowmetry parameters,
along with statistically significant greater PSA reduction
at 6 months, particularly in prostate volumes greater than
80 cc. The objective of this article is to detail our surgical
approach to the anatomic GreenLight laser vaporizationincision technique using the XPS LBO-180W system,
based on extensive personal experience with both
enucleation and vaporization techniques using various
laser technologies. Standardization of the VIT based
on proper cystoscopy, knowledge of prostate anatomy
with preoperative ultrasound, and routine technique
is essential to developing consistent, reproducible and
optimal surgical outcomes.
Keywords
benign prostatic hyperplasia, lower urinary tract symptoms, vaporization-incision technique
Cite This Article
APA Style
Law, K.W., Elterman, D.S., Cash, H., Rijo, E., Chughtai, B. et al. (2019). Anatomic GreenLight laser vaporization-incision technique for benign prostatic hyperplasia using the XPS LBO-180W system: How I do it. Canadian Journal of Urology, 26(5), 9963–9972.
Vancouver Style
Law KW, Elterman DS, Cash H, Rijo E, Chughtai B, Misrai V, et al. Anatomic GreenLight laser vaporization-incision technique for benign prostatic hyperplasia using the XPS LBO-180W system: How I do it. Can J Urology. 2019;26(5):9963–9972.
IEEE Style
K.W. Law et al., “Anatomic GreenLight laser vaporization-incision technique for benign prostatic hyperplasia using the XPS LBO-180W system: How I do it,” Can. J. Urology, vol. 26, no. 5, pp. 9963–9972, 2019.
Copyright © 2019 The Canadian Journal of Urology.